Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 1,194 | N/A | 1,987 | 0 |
| TOTAL | $1,600 | $N/A | $2,386 | $0 |
| Non-Current Assets | ||||
| Investments And Advances | 600,084 | 0 | 600,000 | 0 |
| TOTAL | $600,084 | $N/A | $600,000 | $N/A |
| Total Assets | $601,684 | $N/A | $602,386 | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 49 | 0 | 421 | 0 |
| Accrued Expenses | 1,084 | N/A | 115 | 0 |
| TOTAL | $1,182 | $N/A | $577 | $0 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 574,502 | 0 | 575,810 | 0 |
| TOTAL | $595,502 | $N/A | $596,810 | $N/A |
| Total Liabilities | $596,684 | $N/A | $597,386 | $0 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 75,000 | 75,000 | 75,000 | N/A |
| Common Shares | 2 | N/A | 2 | 0 |
| Retained earnings | 1,228 | N/A | -78 | 0 |
| TOTAL | $5,000 | $N/A | $5,000 | $0 |
| Total Liabilities And Equity | $601,684 | $0 | $602,386 | $0 |